Dosimetric study of the plan quality and dose to organs at risk on tangential breast treatments using the Halcyon linac.

PURPOSE: To investigate the plan quality and doses to the heart, contralateral breast (CB), ipsilateral lung (IL), and contralateral lung (CL) in tangential breast treatments using the Halcyon linac with megavoltage setup fields.
METHODS: Radiotherapy treatment plans with tangential beams from 25 breast cancer patients previously treated on a C-arm linac were replanned for Halcyon. Thirteen corresponded to right-sided breasts and 12 to left-sided breasts, all with a dose prescription of 50 Gy in 25 fractions. Plans were created with the following setup imaging techniques: low-dose (LD) MVCBCT, high-quality (HQ) MVCBCT, LD-MV and HQ-MV pairs and the imaging dose was included in the plans. Plan quality metric values for the lumpectomy cavity, whole-breast and doses to the organs at risk (OARs) were measured and compared with those from the original plans.
RESULTS: No significant differences in plan quality were observed between the original and Halcyon plans. An increase in the mean dose (Mean) for all the organs was observed for the Halcyon plans. For right-sided plans, the accumulated Mean over the 25 fractions in the C-arm plans was 0.4 ± 0.3, 0.2 ± 0.2, 5.4 ± 1.3, and 0.1 ± 0.1 Gy for the heart, CB, IL, and CL, respectively, while values in the MVCBCT-LD Halcyon plans were 1.2 ± 0.2, 0.6 ± 0.1, 6.5 ± 1.4, and 0.4 ± 0.1 Gy, respectively. For left-sided treatments, Mean in the original plans was 0.9 ± 0.2, 0.1 ± 0.0, 4.2 ± 1.2, and 0.0 ± 0.0 Gy, while for the MVCBCT-LD Halcyon plans values were 1.9 ± 0.2, 0.6 ± 0.2, 5.1 ± 1.2, and 0.5 ± 0.2 Gy, respectively.
CONCLUSIONS: Plan quality for breast treatments using Halcyon is similar to the quality for a 6 MV, C-arm plan. For treatments using megavoltage setup fields, the dose contribution to OARs from the imaging fields can be equal or higher than the dose from treatment fields.